Ignite Creation Date:
2025-12-24 @ 1:40 PM
Ignite Modification Date:
2025-12-31 @ 3:06 AM
Study NCT ID:
NCT05460195
Status:
UNKNOWN
Last Update Posted:
2022-07-15
First Post:
2022-07-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sintilimab Combined With Anlotinib for Perioperative Non-small Cell Lung Cancer Based on MRD Evaluation
Sponsor:
Shanghai Chest Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-01-01
Start Date Type:
ACTUAL
Primary Completion Date:
2024-09-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2022-07-03
First Submit QC Date:
None
Study First Post Date:
2022-07-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-07-14
Last Update Post Date:
2022-07-15
Last Update Post Date Type:
ACTUAL